Coronavirus COVID-19: WHO expects anti-malarial drug hydroxychloroquine safety findings by mid-June

The World Health Organization (WHO) on Tuesday (May 26) said that it will conduct a swift review of data on anti-malarial drug hydroxychloroquine by mid-June after the global health body suspended the use of HCQ in a trial on the treatment of coronavirus COVID-19 patients due to safety concerns.

from Zee News :World https://ift.tt/2M2VajS